{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:04:49Z","timestamp":1783112689790,"version":"3.54.6"},"reference-count":75,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2024,3,19]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>Ebola virus disease (EVD) caused by Ebola virus (EBOV) is a severe, often fatal, hemorrhagic disease. A critical component of the public health response to curb EVD epidemics is the use of a replication-competent, recombinant vesicular stomatitis virus (rVSV)-vectored Ebola vaccine, rVSV\u0394G-ZEBOV-GP (ERVEBO). In this Gem, we will discuss the past and ongoing development of rVSV\u0394G-ZEBOV-GP, highlighting the importance of basic science and the strength of public-private partnerships to translate fundamental virology into a licensed VSV-vectored Ebola vaccine.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/jvi.01627-23","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T14:01:20Z","timestamp":1706882480000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":20,"title":["Translational success of fundamental virology: a VSV-vectored Ebola vaccine"],"prefix":"10.1128","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1168-4773","authenticated-orcid":false,"given":"Elizabeth M.","family":"Anderson","sequence":"first","affiliation":[{"name":"Merck &amp; Co., Inc., Rahway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-1073","authenticated-orcid":false,"given":"Beth-Ann G.","family":"Coller","sequence":"additional","affiliation":[{"name":"Merck &amp; Co., Inc., Rahway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-2045-6"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1901594"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuw010"},{"key":"e_1_3_2_5_2","article-title":"Update: filovirus infection in animal handlers","volume":"39","author":"Centers for Disease Control (CDC)","year":"1990","unstructured":"Centers for Disease Control (CDC). 1990. Update: filovirus infection in animal handlers. MMWR Morb Mortal Wkly Rep 39:221.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0227-2"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1807691"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es2014.19.35.20892"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep41613"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9030190"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.78.10.5458-5465.2004"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.10.4477"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060630"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.5.3723-3732.1999"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.06.071"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.47.2.205"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2019.100009"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/514302"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir349"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.26.14764"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.4.3155-3160.1998"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.7.6024-6030.1999"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5458.1664"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.2.1069-1074.2003"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1258"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00561-09"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.09.082"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1209591110"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir298"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.097"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614067"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy020"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32621-6"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.09.009"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.04.066"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz241"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/82_2017_53"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2016.06.008"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00946-0"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/1740774515621037"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.16-1015"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix657"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/1740774518780678"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00040-2"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1080\/17441692.2020.1789194"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002042"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1177\/1740774515619897"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6850a3"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.03.008"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01624-8"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-010996"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2016.1188695"},{"key":"e_1_3_2_54_2","unstructured":"FDA. 2011. Guidance for industry: general principles for the development of vaccines to protect against global infectious diseases. Available from: https:\/\/www.fda.gov\/media\/82306\/download"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2012.01.004"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10030368"},{"key":"e_1_3_2_57_2","unstructured":"FDA. 2015. Guidance for industry: product development under the animal rule. Available from: https:\/\/www.fda.gov\/media\/88625\/download. Retrieved 14 Aug 2023."},{"key":"e_1_3_2_58_2","unstructured":"FDA. 2014. Guidance for industry: expedited programs for serious conditions - drugs and biologics. Available from: https:\/\/www.fda.gov\/media\/86377\/download. Retrieved 14 Aug 2023."},{"key":"e_1_3_2_59_2","unstructured":"WHO. 2015. WHO: Ebola situation report. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/171812. Retrieved 14 Aug 2023."},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3740"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61117-5"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10091446"},{"key":"e_1_3_2_63_2","unstructured":"WHO. 2019. Roadmap for introduction and roll\u2010out of Merck rVSV\u2010ZEBOV Ebola virus disease vaccine in African countries. Available from: https:\/\/www.who.int\/publications\/m\/item\/merck-EVD-vax-intro-roadmap. Retrieved 14 Aug 2023."},{"key":"e_1_3_2_64_2","unstructured":"EMA. 2019. First vaccine to protect against Ebola. Available from: ema.europa.eu\/en\/news\/first-vaccine-protect-against-ebola. Retrieved 14 Aug 2023."},{"key":"e_1_3_2_65_2","unstructured":"WHO. 2019. WHO prequalifies Ebola vaccine paving the way for its use in high-risk countries. Available from: https:\/\/www.who.int\/news-room\/detail\/12-11-2019-who-prequalifies-ebola-vaccine-paving-the-way-for-its-use-in-high-risk-countries. Retrieved 14 Aug 2023."},{"key":"e_1_3_2_66_2","unstructured":"FDA. 2019. First FDA-approved vaccine for the prevention of Ebola virus disease marking a critical milestone in public health preparedness and response. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/first-fda-approved-vaccine-prevention-ebola-virus-disease-marking-critical-milestone-public-health. Retrieved 14 Aug 2023."},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7001a1"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7108a2"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200072"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05035-9"},{"key":"e_1_3_2_73_2","unstructured":"Kroger A Bahta L Long S Sanchez P. 2023. General best practice guidelines for immunization. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(21)00152-1"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000225"},{"key":"e_1_3_2_77_2","unstructured":"UNICEF. 2023. Emergency stockpile availability report - Ebola vaccine. Available from: https:\/\/www.unicef.org\/supply\/documents\/emergency-stockpile-availability-report-ebola-vaccine"},{"key":"e_1_3_2_78_2","unstructured":"Hilleman Laboratories. 2022. Hilleman laboratories to develop a thermostable second-generation Zaire ebolavirus vaccine in collaboration with MSD. Available from: https:\/\/hilleman-labs.org\/press-release\/hilleman-laboratories-to-develop-a-thermostable-second-generation-zaire-ebolavirus-vaccine-in-collaboration-with-msd"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix336"},{"key":"e_1_3_2_80_2","unstructured":"SK bioscience. 2023. SK bioscience announces contract manufacturing agreement with MSD for next-generation Zaire Ebola vaccine candidate. Available from: https:\/\/www.skbioscience.com\/en\/news\/news_01_01?mode=view&id=208&;"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.01627-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.01627-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T18:19:44Z","timestamp":1726510784000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jvi.01627-23"}},"subtitle":[],"editor":[{"given":"Suchetana","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,19]]}},"alternative-id":["10.1128\/jvi.01627-23"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01627-23","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"2024-02-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01627-23"}}